Valneva SE ADR (VALN)

Currency in USD
11.39
-0.08(-0.70%)
Closed·
11.390.00(0.00%)
·
VALN Scorecard
Full Analysis
Significant return over the last week
VALN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.3611.72
52 wk Range
3.6212.25
Key Statistics
Prev. Close
11.39
Open
11.7
Day's Range
11.36-11.72
52 wk Range
3.62-12.25
Volume
178.28K
Average Volume (3m)
91.84K
1-Year Change
95.99%
Book Value / Share
1.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VALN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.43
Upside
+17.87%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Valneva SE ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Valneva SE ADR Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France.

Compare VALN to Peers and Sector

Metrics to compare
VALN
Peers
Sector
Relationship
P/E Ratio
−12.5x−2.3x−0.7x
PEG Ratio
0.160.030.00
Price/Book
4.5x1.3x2.6x
Price / LTM Sales
4.3x4.3x3.4x
Upside (Analyst Target)
18.5%112.8%36.2%
Fair Value Upside
Unlock6.7%4.1%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.43
(+17.87% Upside)

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
-0.1631 / -0.3865
Revenue / Forecast
56.35M / 50.53M
EPS Revisions
Last 90 days

VALN Income Statement

People Also Watch

43.02
SPNS
+0.02%
32.06
VSAT
+3.82%
1.060
OTLK
-0.93%
0.775
ATYR
+9.16%
175.59
LULU
-1.46%

FAQ

What Stock Exchange Does Valneva SE Trade On?

Valneva SE is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Valneva SE?

The stock symbol for Valneva SE is "VALN."

What Is the Valneva SE Market Cap?

As of today, Valneva SE market cap is 986.48M.

What Is Valneva SE's Earnings Per Share (TTM)?

The Valneva SE EPS (TTM) is -0.42.

When Is the Next Valneva SE Earnings Date?

Valneva SE will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is VALN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Valneva SE Stock Split?

Valneva SE has split 0 times.

How Many Employees Does Valneva SE Have?

Valneva SE has 700 employees.

What is the current trading status of Valneva SE (VALN)?

As of 06 Oct 2025, Valneva SE (VALN) is trading at a price of 11.39, with a previous close of 11.39. The stock has fluctuated within a day range of 11.36 to 11.72, while its 52-week range spans from 3.62 to 12.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.